FCG
STLN

Fielder Capital Group’s Starling Oncology Institute, Inc. Common Stock STLN Stock Holding History

Fielder Capital Group’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$215K Hold
70,192
– – 0.05% 267
2025
Q4 		$250K Hold
70,192
– – 0.05% 230
2025
Q3 		$245K Hold
70,192
– – 0.06% 212
2025
Q2 		$144K Hold
70,192
– – 0.04% 235
2025
Q1 		$80K Hold
70,192
– – 0.02% 223
2024
Q4 		$21.7K Hold
70,192
– – 0.01% 212
2024
Q3 		$22.9K Hold
70,192
– – 0.01% 214
2024
Q2 		$32.3K Hold
70,192
– – 0.01% 196
2024
Q1 		$111K Hold
70,192
– – 0.05% 169
2023
Q4 		$143K Buy
+70,192
New +$122K 0.09% 142

Other funds holding STLN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KWM
Kanen Wealth Management Coconut Creek, Florida $278M AUM 38.85% 1-Year Est. Return
JAIC
Josh Arnold Investment Consultant Edina, Minnesota $117M AUM 26.5% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
WC
Wexford Capital West Palm Beach, Florida $690M AUM 57.88% 1-Year Est. Return
CP
CenterBook Partners Greenwich, Connecticut $1.86B AUM 24.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fielder Capital Group's STLN Position: Q1 2026 in Review

Fielder Capital Group held its Starling Oncology Institute, Inc. Common Stock (STLN) position steady in Q1 2026 at 70,192 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #267.

Fielder Capital Group first reported a position in STLN in Q4 2023 and has held it in 10 quarters since. The position peaked at $250K in Q4 2025. 115 funds tracked by Wall St. Rank hold STLN as of Q1 2026.

  • Fielder Capital Group held 70,192 shares of Starling Oncology Institute, Inc. Common Stock worth $215K as of Q1 2026.
  • Fielder Capital Group left its Starling Oncology Institute, Inc. Common Stock share count unchanged in Q1 2026.
  • Starling Oncology Institute, Inc. Common Stock made up 0.05% of Fielder Capital Group's portfolio in Q1 2026, its #267 holding.
  • Fielder Capital Group first reported a position in Starling Oncology Institute, Inc. Common Stock in Q4 2023 and has held it in 10 quarters since.
  • Fielder Capital Group's Starling Oncology Institute, Inc. Common Stock position peaked at $250K in Q4 2025.
  • 115 funds tracked by Wall St. Rank held Starling Oncology Institute, Inc. Common Stock as of Q1 2026.

Based on Fielder Capital Group's 13F filing for Q1 2026, filed 12 May 2026.